Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease | Future Medicinal Chemistry
Table 1 from Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. | Semantic Scholar
VisualAbstract: Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions | 2 Minute Medicine
Placing Novel, Fixed-Dose Dual Bronchodilators within the nice Guidelines for Chronic Obstructive Pulmonary Disease -Reflections on the Past, Present and Future
drugs-respiratory1.ppt
Follow-up treatment of COPD patients. Abbreviations: laMa, long-acting... | Download Scientific Diagram
Preclinical Evaluation of Long-Acting Muscarinic Antagonists: Comparison of Tiotropium and Investigational Drugs | Journal of Pharmacology and Experimental Therapeutics
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Management of stable COPD. SABA, short-acting bronchodilator agonist;... | Download Scientific Diagram
Just Breathe: Clinical Updates in the Treatment of Asthma and COPD - ppt download
New developments in inhaled therapy | Practice Nursing
Understanding the role of long-acting muscarinic antagonists in asthma treatment - Annals of Allergy, Asthma & Immunology
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/4-Table1-1.png "PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar")
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura,
Long‐acting muscarinic antagonists and small airways in asthma: Which link? - Cazzola - 2021 - Allergy - Wiley Online Library
Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis | Journal of Investigative Medicine
Inhaled bronchodilators for chronic bronchitis and emphysema - Document - Gale Academic OneFile
Algorithm showing use of inhaled therapies. FEV 1 , forced expiratory... | Download Scientific Diagram
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD | European Respiratory Society
Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
Pharmacological management of COPD .SABA = short-acting beta 2... | Download Scientific Diagram
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/5-Table2-1.png "PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar")
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
